Disclosures for "Neuropsychiatric Diagnoses Associated with Neurofibromatosis Type 1 in the TriNetX Research Network"
-
Mr. Batheja has nothing to disclose.
-
Prof. Cassel has nothing to disclose.
-
The institution of Dr. Bissonnette has received research support from SAGE Therapeutics. The institution of Dr. Bissonnette has received research support from Huntington's Disease Society of America.